Effects of vitamin K2 supplementation on atherogenic status of individuals with type 2 diabetes: a randomized controlled trial.

BMC Complement Med Ther · 2021 · PMC8088549 · PMID 33933059

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

marginally significantp = 0.052so close (0.05 < p ≤ 0.1)

Effects of vitamin K 2 on atherogenic status Compared to the baseline, a marginally significant reduction was observed in the METS-IR in the vitamin K2 group (mean change from baseline: − 0.80 ± 2.24; p = 0.052).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.